Retrieve available abstracts of 14 articles: HTML format
Single Articles
June 2025
FREEDMAN MS, Clift F, Devonshire V, Emond F, et al First-line use of higher-efficacy disease-modifying therapies in multiple
sclerosis: Canadian consensus recommendations.
Can J Neurol Sci. 2025 Jun 9:1-28. doi: 10.1017/cjn.2025.10342. PubMed
May 2025
FREEDMAN DE, Sundaram ANE, Oh J, Feinstein A, et al How does time of testing influence cognitive performance in multiple sclerosis?
Can J Neurol Sci. 2025 May 19:1-7. doi: 10.1017/cjn.2025.10125. PubMed
March 2025
FIFIELD KE, Fudge NJ, Arsenault ST, Anthony S, et al An overview of multiple sclerosis care in rural and urban Newfoundland and
Labrador.
Can J Neurol Sci. 2025 Mar 12:1-25. doi: 10.1017/cjn.2025. PubMed
NATHOO N, Clark WI, Robinson R, Jarvis S, et al Indigenous Peoples Living with Multiple Sclerosis in Canada.
Can J Neurol Sci. 2025 Mar 4:1-14. doi: 10.1017/cjn.2025. PubMed
GUILLEMETTE A, Roberge D, Menard C, Bahary JP, et al Outcomes of CyberKnife Radiosurgery for Trigeminal Neuralgia in Patients with
Multiple Sclerosis.
Can J Neurol Sci. 2025 Mar 3:1-22. doi: 10.1017/cjn.2025. PubMed
November 2024
SA'DI Q, Alsmadi S, Shtaiyat W, Qasaimeh M, et al FLVCR1 Gene Mutation in a Patient with an Atypical Multiple Sclerosis-Like
Presentation.
Can J Neurol Sci. 2024 Nov 27:1-12. doi: 10.1017/cjn.2024. PubMed
GONCUOGLU C, Acar-Ozen P, Kasikci M, Tuncer A, et al Pharmacist-implemented self-management module in multiple sclerosis patients: A
randomized controlled trial.
Can J Neurol Sci. 2024 Nov 13:1-27. doi: 10.1017/cjn.2024. PubMed
October 2024
MCCOMBE JA, Smyth P, Kate M, So H, et al Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in
Alberta.
Can J Neurol Sci. 2024 Oct 2:1-12. doi: 10.1017/cjn.2024. PubMedAbstract available
May 2024
OH J, Bhan V, Traboulsee A, Morrow SA, et al Health Canada drug approval process: a barrier to personalized care in multiple
sclerosis.
Can J Neurol Sci. 2024 May 23:1-12. doi: 10.1017/cjn.2024. PubMed
April 2024
BALCOM EF, McCombe JA, Kate M, Vu K, et al Geographical variation in medication and health resource use in multiple
sclerosis.
Can J Neurol Sci. 2024 Apr 11:1-21. doi: 10.1017/cjn.2024. PubMed
February 2024
NOBILE S, Beauchemin P Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple
Sclerosis Cohort.
Can J Neurol Sci. 2024 Feb 12:1-21. doi: 10.1017/cjn.2024. PubMed
November 2023
HANDZIC A, Margolin E Myelin Oligodendrocyte Glycoprotein-related isolated internuclear ophthalmoplegia
mimicking multiple sclerosis.
Can J Neurol Sci. 2023 Nov 7:1-5. doi: 10.1017/cjn.2023. PubMed
September 2023
DHAR D, Kamble N, Pal PK Long Latency Reflexes in Clinical Neurology: A Systematic Review.
Can J Neurol Sci. 2023;50:751-763. PubMedAbstract available
April 2023
GIACOMINI PS, Oh J, Morrow SA, Beauchemin P, et al Virtual management of multiple sclerosis: providing access or just phoning it in?
Can J Neurol Sci. 2023 Apr 17:1-11. doi: 10.1017/cjn.2023. PubMed